Systemic interventions for patients with associated cause for bleeding

§ administration of fresh frozen plasma (FFP), platelets or both § factor replacement therapy, using recombinant or plasma‐derived anti‐haemophilic factor A (FVIII) or anti‐haemophilic factor B or VWF § intranasal desmopressin § oral or intravenous tranexamic acid intravenous epsilon amino‐d‐caproic acid